The idea of the three of us, my elderly dog and her two dogs making the trip really stressed me out. When I asked her not to ...

A New York woman had a rare medical condition that required the removal of her kidney. She opted to donate it to a stranger.

Hims & Hers Health (HIMS) stock declined about 2% yesterday. The fall came after the U.S. Food and Drug Administration (FDA) ...

Back in Los Angeles, the new parents often take the same styling tactic. They'll both wear Adidas Sambas or an adjacent, ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $36.85, a high estimate of $68.00, ...

Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business. Read why I think HIMS stock is ...

We recently published a list of 10 Best Telehealth Stocks to Buy Now. In this article, we are going to take a look at where ...

After witnessing other women receive praise online for their nose reveals, one content creator never expected the wave of criticism that followed hers.

Hims & Hers has shown explosive growth, with potential revenue of $2.5B in FY25, trading at a low 2.4x FY25 sales. Learn more ...

The telehealth-consultation platform said it plans to continue expanding its weight loss offerings.

Hims & Hers' Chief Operating Officer Melissa Baird will transition into an advisory role with the telehealth company in the coming months.

Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's weight-loss drug, as it widens its offerings to offset any impact from impending restrictions on selling copies of Novo ...